Therapeutic vaccination offers great promise as an intervention for a diversity of infectious
and non‐infectious conditions. Given that most chronic health conditions are thought to have …

Currently approved replication-competent and inactivated vaccines are limited by excessive
reactogenicity and poor safety profiles, while subunit vaccines are often insufficiently …

Life-inspired protein supramolecular assemblies have recently attracted considerable
attention for the development of next-generation vaccines to fight against infectious …

Biologics (vaccines, monoclonal antibodies (mAb), and genetically modified enzymes) offer
a promising class of therapeutics to treat substance use disorders (SUD) involving abuse of …

The aim of the present study was to improve the immunogenicity of peptide epitope vaccines
using novel nanocarriers based on self-assembling materials. Several studies demonstrated …

Introduction: Substance use disorders (SUD) are a significant threat to both individual and
public health. To date, SUD pharmacotherapy has focused primarily on agonist medications …

Although vaccination is a promising way to combat nicotine addiction, most traditional
hapten-protein conjugate nicotine vaccines only show limited efficacy due to their poor …

Context: Certain antigens, such as haptens (small molecules), short peptides, and
carbohydrates (eg bacterial polysaccharides) are non-or poorly immunogenic unless …

Peptides are generally needed as T-helper epitopes in nicotine vaccines to induce effective
antibody responses, but the highly polymorphic property of major histocompatibility complex …

The landscape of worldwide tobacco use is changing, with a decrease in traditional smoking
and an exponential rise in electronic cigarette use. No new nicotine cessation …